Suppression of CLEC3A inhibits osteosarcoma cell proliferation and promotes their chemosensitivity through the AKT1/mTOR/HIF1α signaling pathway.
Ren C, Pan R, Hou L, Wu H, Sun J, Zhang W, Tian X, Chen H. Mol Med Rep. 2020 Apr; 21(4):1739-1748. Epub 2020 Feb 13.